2 16 Abstract 17 Type 1, or autoimmune, diabetes is caused by the T-cell mediated destruction of the insulin-18 producing pancreatic beta cells. Non-obese diabetic (NOD) mice spontaneously develop 19 autoimmune diabetes akin to human type 1 diabetes. For this reason, the NOD mouse has been 20 the preeminent murine model for human type 1 diabetes research for several decades. However, 21 humanized mouse models are highly sought after because they offer both the experimental 22 tractability of a mouse model and the clinical relevance of human-based research. Autoimmune 23 T-cell responses against insulin, and its precursor proinsulin, play central roles in the 24 autoimmune responses against pancreatic beta cells in both humans and NOD mice. As a first 25 step towards developing a murine model of the human autoimmune response against pancreatic 26 beta cells we set out to replace the murine insulin 1 gene (Ins1) with the human insulin gene 27 (INS) using CRISPR/Cas9. Here we describe a NOD mouse strain that expresses human insulin 28 in place of murine insulin 1, referred to as HuPI. HuPI mice express human insulin, and C-29 peptide, in their serum and pancreata and have normal glucose tolerance. Compared with wild 30 type NOD mice, the incidence of diabetes is much lower in HuPI mice. Only 15-20% of HuPI 31 mice developed diabetes after 300 days, compared to more than 60% of unmodified NOD mice.
226 Discussion
227 Here we describe the generation and characterization of a NOD mouse that expresses human 228 insulin in place of murine insulin 1. We show that human insulin is expressed in the pancreatic 229 islets and human insulin and C-peptide is present in the serum. These mice breed normally, have 230 normal glucose tolerance and are largely protected from diabetes. 231 232 As expected, because the murine insulin 1 gene regulatory elements were left intact, human 233 insulin expression was restricted to the islets of Langerhans. Human insulin and C-peptide were 234 detected in the serum, suggesting that human proinsulin was processed to insulin and C-peptide 235 by murine pancreatic beta cells. The HuPI mice showed no deficit in glucose tolerance, 236 indicating that the combined levels of human insulin and murine insulin 2 were sufficient to 237 maintain normal glucose regulation.
238
239 Surprisingly HuPI mice were protected from spontaneous diabetes. This is similar to the 240 phenotype of murine Ins1 knock-out NOD mice [20] . Moriyama et al [20] found that 241 approximately 10% more Ins1 +/mice developed diabetes than Ins1 -/mice at 300, whereas we 242 did not see any difference in diabetes incidence between HuPI homozygous or heterozygous 243 mice at this time ( Fig 4A) . 244 245 Currently it is not clear how human insulin protects NOD mice from diabetes. One possibility is 246 that the NOD mouse repertoire is 'blind' to human insulin, despite the similarity in the protein 247 sequence between human insulin and murine insulin 1 (Fig 1) . However, this does not account 248 for the protection from diabetes in the HuPI heterozygous mice. In the heterozygous mice the
